Risk Management's Impact on QMS - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Risk Management's Impact on QMS

Risk Management is everywhere, and is not some lofty strategic element that is limited to top floor suits making enterprise-wide decisions. Risk is just another tool in the quiver of the compliance process; it is a method for streamlining your business, like any other compliance process.

Risk Management is becoming an integral part of the compliance process. Like anything else, Risk Management is simply a process. It’s a means of looking at potential hazards, assigning a weight to those hazards, and taking steps to control those hazards. There are many ways to look at Risk, and each industry has developed different risk based tools to suit their specific business needs. Get a glimpse at how compliance industries are utilizing risk as a core benchmarking metric for decision-making in the enterprise. Download White Paper Now.

Web: www.etq.com
Contact: info@etq.com

Profile
EtQ is the leading Quality, EHS, and Operational Risk and Compliance management software provider for identifying, mitigating and preventing high-risk events through integration, automation and collaboration. EtQ is headquartered in Farmingdale, NY, with main offices located in EMEA, the UK, and Arizona.

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
FindPharma Custom Search

Click here